Skip to main content

. 1973 Nov 10;4(5888):337–338. doi: 10.1136/bmj.4.5888.337

Candida albicans septicaemia during first half of pregnancy successfully treated with 5-fluorocytosine.

J Schönebeck, E Segerbrand

PMCID: PMC1587393 PMID: 4202261

337

Images in this article

FIG. 1
on p.338

FIG. 2
on p.338

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Albarracin N. S., Jr, Patterson W. S., Haust M. D. Candida albicans infection of the placenta and fetus. Report of a case. Obstet Gynecol. 1967 Dec;30(6):838–841. [PubMed] [Google Scholar]
Aterman K. Pathology of Candida infection of the umbilical cord. Am J Clin Pathol. 1968 Jun;49(6):798–804. doi: 10.1093/ajcp/49.6.798. [DOI] [PubMed] [Google Scholar]
Chaube S., Murphy M. L. The teratogenic effects of 5-fluorocytosine in the rat. Cancer Res. 1969 Mar;29(3):554–557. [PubMed] [Google Scholar]
Ho C. Y., Aterman K. Infection of the fetus by Candida in a spontaneous abortion. Am J Obstet Gynecol. 1970 Mar;106(5):705–710. doi: 10.1016/0002-9378(70)90394-7. [DOI] [PubMed] [Google Scholar]
Lopez E., Aterman K. Intra-uterine infection by Candida. Am J Dis Child. 1968 Jun;115(6):663–670. doi: 10.1001/archpedi.1968.02100010665005. [DOI] [PubMed] [Google Scholar]
Normark S., Schönebeck J. In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata. Antimicrob Agents Chemother. 1972 Sep;2(3):114–121. doi: 10.1128/aac.2.3.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
Scholer H. J. Antimykoticum 5-Fluorocytosin. (Oral Antimycotic agent, 5-Fluorocytosine) Mykosen. 1970 Apr 1;13(4):179–188. doi: 10.1111/j.1439-0507.1970.tb01248.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES